新辅助治疗
乳腺癌
医学
病态的
完全响应
肿瘤科
癌症
内科学
化疗
作者
G Sa,Pedro Vilar de Oliveira Villarim,P. Gallardo Melo,Ayane Cristine Alves Sarmento,Ana Katherine Gonçalves,Kleyton Santos de Medeiros,Cristina Miranda
标识
DOI:10.61622/rbgo/2025rbgo13
摘要
Neoadjuvant therapy demonstrated significant efficacy in achieving pathological response in breast cancer patients. We observed a strong association between the AC-TH regimen, HER2-positive status, and pCR.
科研通智能强力驱动
Strongly Powered by AbleSci AI